EE04315B1 - 6,9-diasendatud-2-[trans-(4-aminotsükloheksüül)amino]puriinid - Google Patents

6,9-diasendatud-2-[trans-(4-aminotsükloheksüül)amino]puriinid

Info

Publication number
EE04315B1
EE04315B1 EEP200000501A EEP200000501A EE04315B1 EE 04315 B1 EE04315 B1 EE 04315B1 EE P200000501 A EEP200000501 A EE P200000501A EE P200000501 A EEP200000501 A EE P200000501A EE 04315 B1 EE04315 B1 EE 04315B1
Authority
EE
Estonia
Prior art keywords
aminocyclohexyl
purines
disubstituted
trans
amino
Prior art date
Application number
EEP200000501A
Other languages
English (en)
Inventor
Ann Dumont Jennifer
Joseph Bitonti Alan
Roger Borcherding David
Paul Peet Norton
Randall Munson Harry
Wai-Kwok Shum Patrick
Original Assignee
Aventis Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc. filed Critical Aventis Pharmaceuticals Inc.
Publication of EE200000501A publication Critical patent/EE200000501A/et
Publication of EE04315B1 publication Critical patent/EE04315B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EEP200000501A 1998-02-26 1999-02-18 6,9-diasendatud-2-[trans-(4-aminotsükloheksüül)amino]puriinid EE04315B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3238198A 1998-02-26 1998-02-26
PCT/US1999/003451 WO1999043676A2 (en) 1998-02-26 1999-02-18 6,9-disubstituted 2-[trans-(4- aminocyclohexyl) amino]purines

Publications (2)

Publication Number Publication Date
EE200000501A EE200000501A (et) 2002-02-15
EE04315B1 true EE04315B1 (et) 2004-06-15

Family

ID=21864658

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000501A EE04315B1 (et) 1998-02-26 1999-02-18 6,9-diasendatud-2-[trans-(4-aminotsükloheksüül)amino]puriinid

Country Status (31)

Country Link
EP (1) EP1056745B1 (et)
JP (1) JP2002504553A (et)
KR (1) KR100568658B1 (et)
CN (1) CN1128149C (et)
AP (1) AP1258A (et)
AR (1) AR019822A1 (et)
AT (1) ATE269332T1 (et)
AU (1) AU748178B2 (et)
BR (1) BR9908325A (et)
CA (1) CA2320448C (et)
CZ (1) CZ291604B6 (et)
DE (1) DE69918062T2 (et)
DK (1) DK1056745T3 (et)
EE (1) EE04315B1 (et)
ES (1) ES2219038T3 (et)
HK (1) HK1030948A1 (et)
HU (1) HUP0100931A3 (et)
IL (2) IL138044A0 (et)
NO (1) NO20004281L (et)
NZ (1) NZ506234A (et)
OA (1) OA11480A (et)
PL (1) PL344021A1 (et)
PT (1) PT1056745E (et)
RU (1) RU2191777C2 (et)
SI (1) SI1056745T1 (et)
SK (1) SK12912000A3 (et)
TR (1) TR200002482T2 (et)
TW (1) TW541308B (et)
UA (1) UA62996C2 (et)
WO (1) WO1999043676A2 (et)
ZA (1) ZA991548B (et)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627633B2 (en) 1999-03-17 2003-09-30 Albany Molecular Research, Inc. 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents
US6969720B2 (en) 1999-03-17 2005-11-29 Amr Technology, Inc. Biaryl substituted purine derivatives as potent antiproliferative agents
US20030187261A1 (en) * 2000-01-07 2003-10-02 Libor Havlicek Purine derivatives, process for their preparation and use thereof
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
HN2001000008A (es) 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
FR2806626B1 (fr) * 2000-03-22 2003-11-28 Centre Nat Rech Scient Utilisation de substances modulatrices de l'expression ou de la fonction d'une proteine impliquee dans le cycle cellulaire pour le traitement ou la prevention des lesions neurales aigues
WO2001079198A1 (en) 2000-04-18 2001-10-25 Agouron Pharmaceuticals, Inc. Pyrazoles for inhibiting protein kinase
CA2411928A1 (en) 2000-08-09 2002-02-14 Agouron Pharmaceuticals, Inc. Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclindependent kinases
ATE295354T1 (de) 2000-08-18 2005-05-15 Agouron Pharma Heterozyklische-hydroximino-fluorene und ihre verwendung zur inhibierung von proteinkinasen
JP4348081B2 (ja) * 2000-10-31 2009-10-21 アベンティス・ファーマスーティカルズ・インコーポレイテツド ６，９−二置換２−（トランス−１，４−ジアミノシクロヘキシル）−プリンのアシル及びスルホニル誘導体及び抗増殖剤としてのその使用
GB0117075D0 (en) * 2000-10-31 2001-09-05 Aventis Pharm Prod Inc Acyl and sulfonyl derivatives of 6, 9-distributed 2-(trans-1, 4-diaminocyclohexyl)-purines and their use as antiproliferative agents
US6756374B2 (en) 2001-01-22 2004-06-29 Hoffmann-La Roche Inc. Diaminothiazoles having antiproliferative activity
DE60205376T2 (de) 2001-06-27 2006-04-06 Cyclacel Ltd. 2,6,9-substituierte purinderivate und ihre verwendung bei der behandlung proliferativer krankheiten
US6812232B2 (en) 2001-09-11 2004-11-02 Amr Technology, Inc. Heterocycle substituted purine derivatives as potent antiproliferative agents
US6667311B2 (en) 2001-09-11 2003-12-23 Albany Molecular Research, Inc. Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents
GB0219052D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New puring derivatives
GB0219054D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New purine derivatives
JPWO2004069233A1 (ja) * 2003-02-04 2006-05-25 株式会社ヤクルト本社 乳癌耐性蛋白阻害剤
US7211576B2 (en) 2004-04-20 2007-05-01 Hoffmann-La Roche Inc. Diaminothiazoles
MX2008012515A (es) * 2006-03-30 2008-11-19 Ptc Therapeutics Inc Metodos para la produccion de proteina funcional a partir de adn que tiene una mutacion sin sentido y el tratamiento de trastornos asociados con la misma.
EP2209786B1 (en) * 2007-10-05 2013-02-27 Verastem, Inc. Pyrimidine substituted purine derivatives
CN102241646B (zh) * 2010-05-14 2014-04-09 中国人民解放军军事医学科学院毒物药物研究所 己烯酮类化合物及其医药用途
WO2013130461A1 (en) 2012-02-29 2013-09-06 The Scripps Research Institute Wee1 degradation inhibitors
WO2015005491A1 (ja) * 2013-07-12 2015-01-15 国立大学法人京都大学 疾病の発症又は進行の一因となる異常スプライシングを抑制できる物質のスクリーニング方法
EP4115882A1 (en) 2015-01-16 2023-01-11 The General Hospital Corporation Compounds for improving mrna splicing
CN107903274A (zh) * 2017-12-28 2018-04-13 窦玉玲 一种胺类化合物及其在抗肿瘤药物中的应用
EP3997089A4 (en) * 2019-07-21 2023-08-16 University Of Virginia Patent Foundation CYSTEINE BINDING COMPOSITIONS AND METHODS OF USE THEREOF

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
GB9414208D0 (en) * 1994-07-14 1994-08-31 Glaxo Group Ltd Compounds
ATE236161T1 (de) * 1995-11-01 2003-04-15 Novartis Pharma Gmbh Purinderivate und verfahren zu ihrer herstellung
FR2741881B1 (fr) * 1995-12-01 1999-07-30 Centre Nat Rech Scient Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques

Also Published As

Publication number Publication date
CA2320448C (en) 2005-02-01
TW541308B (en) 2003-07-11
SI1056745T1 (en) 2004-12-31
HUP0100931A3 (en) 2002-08-28
EP1056745B1 (en) 2004-06-16
HUP0100931A2 (hu) 2002-04-29
JP2002504553A (ja) 2002-02-12
TR200002482T2 (tr) 2002-10-21
KR100568658B1 (ko) 2006-04-07
OA11480A (en) 2004-05-05
WO1999043676A2 (en) 1999-09-02
AU748178B2 (en) 2002-05-30
DE69918062D1 (de) 2004-07-22
DK1056745T3 (da) 2004-10-25
EP1056745A2 (en) 2000-12-06
NO20004281D0 (no) 2000-08-25
CN1291983A (zh) 2001-04-18
CA2320448A1 (en) 1999-09-02
CZ20003106A3 (cs) 2000-12-13
EE200000501A (et) 2002-02-15
AP1258A (en) 2004-03-15
HK1030948A1 (en) 2001-05-25
SK12912000A3 (sk) 2001-08-06
PL344021A1 (en) 2001-09-24
CZ291604B6 (cs) 2003-04-16
BR9908325A (pt) 2000-11-07
ES2219038T3 (es) 2004-11-16
IL138044A0 (en) 2001-10-31
AU3299099A (en) 1999-09-15
NO20004281L (no) 2000-10-18
WO1999043676A3 (en) 1999-10-21
CN1128149C (zh) 2003-11-19
DE69918062T2 (de) 2005-06-02
AP2000001923A0 (en) 2000-09-30
IL138044A (en) 2006-04-10
AR019822A1 (es) 2002-03-20
UA62996C2 (en) 2004-01-15
KR20010041315A (ko) 2001-05-15
NZ506234A (en) 2003-05-30
ZA991548B (en) 1999-08-26
ATE269332T1 (de) 2004-07-15
RU2191777C2 (ru) 2002-10-27
PT1056745E (pt) 2004-09-30

Similar Documents

Publication Publication Date Title
EE200000489A (et) 6,9-diasendatud-2-[trans-(4-aminotsükloheksüül)amino]puriinid
EE04315B1 (et) 6,9-diasendatud-2-[trans-(4-aminotsükloheksüül)amino]puriinid
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
PT891978E (pt) Derivados de 5h-tiazolo (3,2-a) pirimidina
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
NO20003825L (no) 1,3,4 - oxadiazolonderivater
ATE234839T1 (de) 4,5-azolo-oxindole
FR2778528B1 (fr) Balancier, element de cornadis, cornadis
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
PT1056744E (pt) 2-¬trans-(4-aminociclo-hexil)amino|purinas 6,9-dissubstituidas
NO982469D0 (no) Herbicide 3,5-Difluorpyridiner
ID26084A (id) Turunan-turunan amino antrasiklinon
PT887349E (pt) Derivados de tetra-hidro-imidazo¬2,1-a|isoquinolina
FI981420A0 (fi) Jatkopistokytkin
SI1056744T1 (en) 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino)purines
DE29813055U1 (de) Stellwinkel (P)
FI981421A (fi) Jatkopistokytkin

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

GB1A Change in the ownership or in the address of the owner
MM4A Lapsed by not paying the annual fees

Effective date: 20100218